-
-
For unvaccinated or high-risk vaccinated patients during the influenza season, empirical oseltamivir treatment is cost-effective. For other patients, rapid diagnostic testing followed by treatment with oseltamivir is cost-effective. Empirical amantadine treatment offers a low-cost alternative if patients cannot afford oseltamivir.
-
As determined by process-of-care measurement, adverse event occurrence, and patient satisfaction, quality of care is compromised by infection control procedures.
-
The FDA has approved the first once-daily, quaternary ammonium, anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease.
-
Few clinical situations place intensive care practitioners in a more uncomfortable position than does treating patients of the Jehovahs Witness faith. The faith-based refusal of autogenous or allogenic blood transfusions conflicts with the typical life-saving intent implicit in the critical care environment. However, it is our obligation to have a basic level of understanding of the set of beliefs that leads to the choice to refuse this specific set of life-saving therapies, while accepting other aspects of modern medical care.
-
Antibiotics Associated With Cancer Risk; Topiramate Effective Against Migraine; Statin Therapy For Heart Failure; FDA Actions.
-
-
A small subset of patients with evidence of pericardial constriction, perhaps 1 in 6, experience spontaneous resolution without surgical intervention.
-
The risk of new AF or HF in subjects older than 65 with echocardiographic evidence of abnormal relaxation increased linearly with the degree of LA enlargement.
-
Kahn and colleagues preformed a randomized trial of CPB vs off-pump coronary artery surgery in 104 patients with multivessel disease; Cavendish and associates report on 5 cases in which the Symmetry Bypass Connector was used, who developed acute coronary syndromes 2-5 months after surgery.